F8 and hemophilia A: With a view to increasing FVIII expression, we modified our canine (c) B domain-deleted (BDD) FVIII transgene that was used in an ex vivo gene delivery strategy30 and to produce recombinant FVIII for dogs in our hemophilia A colony.